The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have opened a call for evidence on a Wellcome-funded programme intended to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools.
The survey opened on 5 November 2026 and will remain open until 26 February 2027.
Who is being asked to respond
The two organisations are seeking feedback from a wide range of stakeholders: developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers and regulators, as well as people with lived experience of mental health conditions, carers and members of the public.
What the evaluation covers
According to the MHRA and NICE, the survey forms part of the programme's Phase 1 evaluation and is designed to assess how the resources have been received and used across the sector. The organisations said they are particularly interested in understanding whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
Findings from the exercise will be used to establish whether the Phase 1 outputs achieved their intended objectives and will inform the future direction of Phase 2 of the Digital Mental Health Technologies (DMHT) programme.
Scope of participation
The organisations encouraged stakeholders to take part whether they have engaged extensively, minimally or not at all with the existing resources. The feedback, they said, will help identify strengths, highlight areas for improvement and shape future work aimed at improving the safety and effectiveness of digital mental health technologies.